Allurion shares soar 77% after sharing plans for GLP-1RA combo trial
If you can’t beat them then join them. In a bid to combat weakening financial performance, Allurion has revealed plans …
Post
-
-
Median Technologies secures €47.5m to commercialise cancer diagnostic
Median Technologies has secured up to €47.5m ($49.9m) to support the regulatory filing and commercialisation efforts for its suite of …
-
Pulsed-field ablation: A major upgrade in treating irregular heartbeats
Irregular heart rhythms, or arrhythmias, affect millions of people worldwide and range from benign conditions to serious, life-threatening disorders. Left …
-
Abyssinia and Cordance link on ultrasound applications for Alzheimer’s
Abyssinia Biosciences and Cordance Medical have agreed to explore the potential of focused ultrasound for the diagnosis and treatment of …
-
Schweitzer Engineering Laboratories to manufacture early autism diagnostic
Schweitzer Engineering Laboratories (SEL) is expanding into the medical device sector to produce a diagnostic for early autism spectrum disorder …
-
GE HealthCare and Nuffield sign $247m deal to bolster diagnostic services in UK
GE HealthCare and Nuffield Health have entered a £200m ($246.6m) deal to bolster diagnostic imaging services across Nuffield Health's hospitals …
-
Medical Device Network Excellence Awards 2024: KOB GmbH
KOB GmbH (KOB), a global B2B manufacturer of medical devices and elastic special textiles, has won the Innovation award in …
-
Merck and Opentrons to automate assay kits on custom workstation
Merck KGaA (Merck) and Opentrons Labworks have announced a partnership to automate assay kits on a ‘custom’ Opentrons Flex workstation. The …
-
Lunit’s SCOPE AI tools demonstrate value in HER2 biomarker evaluation
A new study has demonstrated the value of Lunit’s AI-powered pathology tools in improving human epidermal growth factor receptor 2 …
-
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics …
-
Vantis Vascular completes first commercial use of CrossFAST system
Vantis Vascular has completed the first commercial application of its CrossFAST Integrated Microcatheter Advanced Delivery System. The procedures were carried out …
-
Leica partners with Molecular Instruments for fluorescent RNA assay integration
Leica Biosystems has partnered with Molecular Instruments (MI) to integrate its imaging assay with Leica’s BOND series of research staining …
-
What is the Stargate project and why does it matter?
The Stargate project announcement on OpenAI’s website ends with a call for collaboration with companies “across the built data centre …
-
Mayo Clinic joins SeaStar Medical for acute kidney injury trial
Mayo Clinic has joined SeaStar Medical as the 15th site authorised to enrol subjects for the company’s pivotal NEUTRALIZE-AKI trial …
-
Trump’s trade, tech wars to hit ‘businesses in all sectors all over the world’
The trade and tech wars that Donald Trump is expected to unleash as central pillars of his second US presidency …
